Reported Reactions

Devices › Implantable pacemaker pulse-generator

Device brand name · Implantable pulse generator

Insignia I Plus Dddro Is-1: medical device reports filed with FDA

325 reports name it, 2009–2010. Manufacturer given most often on reports: Guidant Crm Clonmel Ireland. Product code DXY.

325
device reports naming the brand
0% of all MAUDE reports · about 19 a year
0
reports, 12 months to August 2026
0 in the 12 months before
36.6%
classified as malfunction
41.2% across the product code
0.9%
classified as death, as reported
3 reports · not verified by FDA

FDA's MAUDE database holds 325 reports that name the brand "Insignia I Plus Dddro Is-1" (implantable pulse generator), received between February 2009 and May 2010; the manufacturer given most often on reports is Guidant Crm Clonmel Ireland. Spellings of one product vary from report to report.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (62.2%), malfunction (36.6%) and death (0.9%); across all implantable pacemaker pulse-generator reports (product code DXY) death is recorded in 3.4% and malfunction in 41.2%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are pacing problem (17.8%), normal (14.8%) and failure to capture (9.8%). The patient problems coded most often are other (for use when an appropriate patient code cannot be identified), syncope and pocket erosion. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

No report naming Insignia I Plus Dddro Is-1 was received in the five years to August 2026; the latest was received in May 2010.

Event type and report source

Event type, as classified on the report

Death0.9%3
Injury62.2%202
Malfunction36.6%119
Other0.3%1
Not given0%0

Who filed the report

Manufacturer report100%325
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 57,832 reports carrying product code DXY. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Pacing problem5817.8%6.4%
Normal4814.8%2%
Failure to capture329.8%6.3%
Low battery309.2%5.3%
Over-sensing309.2%5.4%
Pacing inadequately247.4%1.2%
Noise216.5%1%
Insufficient device problem information154.6%0.9%
Malfunction123.7%1.9%
Device sensing problem113.4%0.9%
Difficult to interrogate103.1%3.1%
High impedance103.1%3.8%
Premature discharge of battery92.8%8.4%
Performance72.2%0.4%
Failure to sense61.8%1.4%
Sensing intermittently61.8%0.7%
Telemetry discrepancy61.8%2.3%
Communication or transmission problemthe device could not communicate or transmit51.5%1.2%
Connection error51.5%0.7%
Connection problema connection problem51.5%1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Other (for use when an appropriate patient code cannot be identified)4513.8%
Syncopefainting3410.5%
Pocket erosion103.1%
Deaththe patient died; cause not stated by this term41.2%
Ventricular tachycardiaa fast rhythm from the lower heart chambers41.2%
Atrial fibrillationan irregular heart rhythm30.9%
Falla fall30.9%
Bradycardiaslow heart rate20.6%
Cardiopulmonary arrest20.6%
Arrhythmia10.3%
Asystole10.3%
Atrial flutter10.3%
Complaint, ill-defined10.3%
Congestive heart failure10.3%
Dizzinesslight-headedness or unsteadiness10.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureInsignia I Plus Dddro Is-1Product code DXYAll MAUDE reports
Reports32557,83226,136,888
Share of that pool—0.6%0%
Classified as death, per 1,000 reports9349
Classified as injury62.2%54.4%36.2%
Classified as malfunction36.6%41.2%62.3%
Filed by the manufacturer100%96.6%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DXY

BrandReportsLatest 12 monthsClassified as death
Tendril Mri7,0764224.1%
Medtronic Lead2,3513289.5%
Carelink Program W/Telemetry C1,68100%
Carelink15,005180%
Assurity Mri18,9952,0351.8%
Insignia Plus94009.1%
Insignia Ultra79705.4%
Meta Dddr53200.4%
Enpulse606310.4%
Medtronic ICD40410523.8%
Insignia Entra374010.2%
Anthem Rf37204.3%
Tempo7211550.7%
Medtronic2,953174.4%
Symphony1,1631331.6%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Insignia I Plus Dddro Is-1 reports

How many FDA reports name Insignia I Plus Dddro Is-1?

325 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

injury (62.2%), malfunction (36.6%) and death (0.9%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

pacing problem (17.8%), normal (14.8%), failure to capture (9.8%), low battery (9.2%) and over-sensing (9.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Insignia I Plus Dddro Is-1 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.